SCHEMBL2266737

SCHEMBL2266737

Cc1ccc(S(=O)(=O)Cl)c(C)c1S(=O)(=O)Cl

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 3/20 0.36
ALDH1A1 P00352 4/20 0.33
TSHR P16473 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.31
TDP2 O95551 1/20 0.31
NSD2 O96028 1/20 0.31
HSP90AA1 P07900 1/20 0.31
PAX8 Q06710 1/20 0.31
KMT2A Q03164 2/20 0.30
MEN1 O00255 1/20 0.30
CYP1A2 P05177 1/20 0.30
PKM P14618 1/20 0.30
CYP2C19 P33261 1/20 0.30
NR2F2 P24468 1/20 0.30
GAA P10253 1/20 0.30
HSD17B10 Q99714 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4091751 0.84 TDP2 (0.39) ALDH1A1TSHRTDP2NSD2HSP90AA1
SCHEMBL2930464 0.82 ALDH1A1 (0.44) TRPV4ALDH1A1TSHRL3MBTL1TDP2
SCHEMBL30039434 0.82 ALDH1A1 (0.44) TRPV4ALDH1A1TSHRL3MBTL1TDP2
SCHEMBL4616553 0.80 HTT (0.45) ALDH1A1L3MBTL1KMT2AMEN1CYP2C19
SCHEMBL31453875 0.78 TRPV4 (0.40) TRPV4ALDH1A1TSHRL3MBTL1TDP2
SCHEMBL4618011 0.77 KMT2A (0.39) TRPV4ALDH1A1TSHRL3MBTL1TDP2
SCHEMBL29907244 0.77 TRPV4 (0.35) TRPV4ALDH1A1TSHRL3MBTL1TDP2
SCHEMBL27142253 0.77 TRPV4 (0.35) TRPV4ALDH1A1TSHRL3MBTL1TDP2
SCHEMBL251515 0.74 KMT2A (0.37) TRPV4ALDH1A1TSHRL3MBTL1KMT2A
SCHEMBL4187153 0.72 TRPV4 (0.35) TRPV4ALDH1A1TSHRL3MBTL1TDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8445440-B2 Dimeric IAP inhibitors NOVARTIS AG (CH) 2013-05-21 US disclosed
EP-2539333-A1 DIMERIC IAP INHIBITORS Novartis AG (CH) 2013-01-02 EP disclosed
WO-2011104266-A1 DIMERIC IAP INHIBITORS NOVARTIS AG (CH) 2011-09-01 WO disclosed
US-20110206690-A1 DIMERIC IAP INHIBITORS NOVARTIS AG (CH) 2011-08-25 US disclosed
US-4438245-A FOR LIGHT SENSITIVE ELEMENTS FUJI PHOTO FILM CO., LTD. (JP) 1984-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110206690-A1 DIMERIC IAP INHIBITORS XIAP, BIRC5, BIRC2 TRPV4 4223/4885ALDH1A1 4127/4885TSHR 4630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.